- Home
- NYXH vs SERA Comparison
NYXH vs SERA Comparison
Compare NYXH & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NYXH | SERA |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.6M | 75.2M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NYXH | SERA |
|---|---|---|
| Price | $0.90 | $2.00 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.82 | N/A |
| AVG Volume (30 Days) | ★ 261.4K | 38.3K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $81,000.00 |
| Revenue This Year | $234.49 | $146.91 |
| Revenue Next Year | $98.07 | $933.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $0.80 | $1.56 |
| 52 Week High | $5.39 | $3.85 |
Technical Indicators
Market Signals| Indicator | NYXH | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 37.77 | 46.41 |
| Support Level | $0.80 | $1.97 |
| Resistance Level | $0.97 | $2.07 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 57.35 | 25.81 |
Price Performance
Historical ComparisonAbout NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.